Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Oxidative Cyclization‐Induced Activation of a Phosphoinositide 3‐Kinase Inhibitor for Enhanced Selectivity of Cancer Chemotherapeutics
Haizhou Zhu, Rosalin Mishra, Long Yuan, et al.
ChemMedChem (2019) Vol. 14, Iss. 22, pp. 1933-1939
Closed Access | Times Cited: 9

Showing 9 citing articles:

PI3K Inhibitors in Cancer: Clinical Implications and Adverse Effects
Rosalin Mishra, Hima Patel, Samar Alanazi, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 7, pp. 3464-3464
Open Access | Times Cited: 198
Selectfluor-Mediated Regioselective C-3 Alkoxylation, Amination, Sulfenylation, and Selenylation of Quinoxalin-2(1H)-ones
Sonam Sonam, Vikki N. Shinde, Krishnan Rangan, et al.
The Journal of Organic Chemistry (2023) Vol. 88, Iss. 4, pp. 2344-2357
Closed Access | Times Cited: 17
Targeting the PI3K/AKT signaling pathway in anticancer research: a recent update on inhibitor design and clinical trials (2020–2023)
Dima A. Sabbah, Rima Hajjo, Sanaa K. Bardaweel, et al.
Expert Opinion on Therapeutic Patents (2024) Vol. 34, Iss. 3, pp. 141-158
Closed Access | Times Cited: 6
Development and Evolution of DNA-Dependent Protein Kinase Inhibitors toward Cancer Therapy
Yoshihisa Matsumoto
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 8, pp. 4264-4264
Open Access | Times Cited: 22
Unveiling the Role of PIK3R1 in Cancer: A Comprehensive Review of Regulatory Signaling and Therapeutic Implications
Ishita Gupta, Daria A. Gaykalova
Seminars in Cancer Biology (2024) Vol. 106-107, pp. 58-86
Closed Access | Times Cited: 4
Phosphoinositide 3-Kinase (PI3K) Reactive Oxygen Species (ROS)-Activated Prodrug in Combination with Anthracycline Impairs PI3K Signaling, Increases DNA Damage Response and Reduces Breast Cancer Cell Growth
Rosalin Mishra, Long Yuan, Hima Patel, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 4, pp. 2088-2088
Open Access | Times Cited: 17
Development of a bioavailable boron-containing PI-103 Bioisostere, PI-103BE
Lan Luo, Qiu Zhong, Shanchun Guo, et al.
Bioorganic & Medicinal Chemistry Letters (2020) Vol. 30, Iss. 14, pp. 127258-127258
Open Access | Times Cited: 12
RIDR-PI-103, ROS-activated prodrug PI3K inhibitor inhibits cell growth and impairs the PI3K/Akt pathway in BRAF and MEK inhibitor-resistant BRAF-mutant melanoma cells
Hima Patel, Rosalin Mishra, Adam D. Wier, et al.
Anti-Cancer Drugs (2023)
Open Access | Times Cited: 3
Metal-free regioselective nitration of quinoxalin-2(1H)-ones with tert-butyl nitrite
Yina Li, Xuelin Li, Jin-Bo Wu, et al.
Organic & Biomolecular Chemistry (2021) Vol. 19, Iss. 48, pp. 10554-10559
Closed Access | Times Cited: 7
Page 1

Scroll to top